Company Performance Metrics
- Aamir Mahmood: President and CEO
- Samuel Schmidt: Co-founder
Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The research group received the award, ‘MedicoPrisen’, from Medicoindustrien (Danish Medtech trade association) in 2007. A research and development collaboration was established in 2007 between Aalborg University and Coloplast A/S,
receiving public support from the Danish National Advanced Technology Foundation in 2008. Acarix A/S was established in 2009 as a spin-out company from Coloplast A/S with Coloplast A/S and Aalborg University as the major shareholders.
In 2010 Acarix A/S succeeded attracting venture capital from Seed Capital (DK), Sunstone Capital (DK) and Seventure Partners (F).
In 2011 Acarix A/S and collaborators furthermore achieved funding of 5.3 million DKK from the Danish Business Innovation Fund.
